EMA Unveils Revamped Human Medicines Unit
Old Hands To Head Up New Task Forces
Europe’s top drugs regulator has reorganized its operations to tackle what it calls “fundamental changes” brought by new legislative initiatives, digital technologies, global trends in science, and staff losses due to Brexit. More changes are to be implemented during the course of 2020 in a bid to optimize the agency’s regulatory and scientific output.
You may also be interested in...
The change in leadership at the European Medicines Agency comes at a critical time.
Currently serving at the WHO, Emer Cooke is set to return to the EMA later this year in the role of executive director. She will have to tackle challenges posed by Brexit, COVID-19 and recent agency restructuring.
A new executive director will be chosen for the European Medicines Agency on 25 June. The agency's management board has two candidates from which to choose.